Figure 3.
Crossreactivity of circulating MAIT cells from healthy donors. (A) Percentage of CD137+ MAIT cells following activation by A375b-MR1 cells ± aMR1 mAb. MAIT cell lines were previously generated from two donors by in vitro expansion with 5-OP-RU. (B) Plots of MAIT cell lines stained with MR1-3-F-SA tetramer vs. CTV. Cells were pregated on CD161+ cells. Data were obtained from a total of two donors. (C) Representative plots of MAIT cell lines stained with MR1-6-FP tetramer vs. CTV. Cells were pre-gated on CD161+ cells. Data was obtained from a total of two donors. (D) Populations of MAIT cells that are double positive for MR1-3-F-SA and MR1-6-FP tetramers in the same two donors (B–D). (E) Frequency of MR1-5-OP-RU, -6-FP, -3-F-SA, or -5-F-SA MR1 tetramer+ cells from two additional MAIT cell lines derived from the peripheral blood of donors 3 and 4. Pie segments indicate cells positive for any combination of the four tetramer sets. Pie arcs indicate the tetramer positivity of each segment. Percentages indicate the total number of cells positive for at least one tetramer. (F) Percentage of ex vivo MAIT cells from healthy donors stained with at least one of three tetramers: CD8-null MR1-3-F-SA, -5-F-SA, or -6-FP. MAIT cells were pregated on live CD3+/Vα7.2+/CD161+/CD26+ cells. Non-MAIT cells were pregated on live CD3+/Vα7.2− cells. Statistical significance was determined using Student’s t test, ** P ≤ 0.01. Source data are available for this figure: SourceData F3.